LEONARD JOHN M

Average Profitability
38.28%
Insider Buys Quantity
2
Insider Buys Sum
$326,760.00
Insider Sells Quantity
28
Insider Sells Sum
$82.87M

Insider Activity of LEONARD JOHN M

According to the SEC Form 4 filings, LEONARD JOHN M, being in a position of

  1. President and CEO at Intellia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 19223 shares for $566,310,
    over all time since 2018-05-14, has bought 0 shares, and sold 1107738 shares for $74.49M.

The largest purchase of all time was on 2014-11-05 and amounted to 8000 shares of Chimerix, Inc. for $232,000.

The largest sale of all time was on 2021-02-01 and amounted to 219778 shares of Intellia Therapeutics, Inc. for $14.07M.

Biography of LEONARD JOHN M

No biography is available at this moment.

2024-01-03SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
19,223
0.0215%
$29.46$566,310-19.78%
2023-01-04SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
6,673
0.0072%
$37.21$248,302-3.48%
2022-01-01SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
2,493
0.0032%
$112.25$279,852
2021-09-01SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
44,735
0.0629%
$170.00$7.6M-53.54%
2021-08-31SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
37,833
0.0496%
$155.00$5.86M-51.39%
2021-08-30SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
38,804
0.0533%
$155.95$6.05M-48.07%
2021-08-23SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
27,139
0.0354%
$152.01$4.13M-46.9%
2021-08-19SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
22,682
0.0323%
$151.28$3.43M-41.29%
2021-04-01SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
76,418
0.1171%
$83.64$6.39M+41.31%
2021-02-09SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
56,086
0.0855%
$75.00$4.21M+54.44%
2021-02-05SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
45,884
0.0668%
$67.66$3.1M+63.76%
2021-02-03SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
135,712
0.22%
$72.54$9.84M+69.86%
2021-02-01SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
219,778
0.3264%
$64.00$14.07M+76.35%
2021-01-05SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
12,478
0.017%
$55.86$697,021+85.43%
2020-11-27SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
55,000
0.0966%
$38.73$2.13M+103.3%
2020-11-25SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
100,000
0.1067%
$21.41$2.14M+122.03%
2020-11-16SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
40,000
0.0505%
$24.29$971,600+127%
2020-11-04SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
100,000
0.1079%
$16.41$1.64M+177.2%
2020-10-07SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
10,000
0.0108%
$14.33$143,300+200.17%
2020-09-01SaleIntellia Therapeutics, Inc.
NTLA
President and CEO
10,000
0.0115%
$14.33$143,300+214.4%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.